Function and regulation of SPLUNC1 protein in mycoplasma infection and allergic inflammation

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3995-4002

  Hong, Wei Chu ^a   Thaikoottathil, Jyoti ^a   Rino, John G ^a   Zhang, Gongyi ^a   Wu, Qun ^a   Moss, Taylor ^a   Refaeli, Yosef ^a   Bowler, Russell ^a   Wenzel, Sally E ^b   Chen, Zhongzhou ^a   Zdunek, Jeffrey ^a   Breed, Rachel ^a   Young, Ryan ^a   Allaire, Erin ^a   Martin, Richard J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 8; LIPOPROTEIN; MEMBRANE PROTEIN; PROTEIN SPLUNC1; UNCLASSIFIED DRUG; AUTACOID; GLYCOPROTEIN; PHOSPHOPROTEIN; PLUNC PROTEIN, HUMAN; PLUNC PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; RNA INTERFERENCE; TH2 CELL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MYCOPLASMA PNEUMONIAE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT MUCOSA; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LIPOPROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYCOPLASMA PNEUMONIAE; PHOSPHOPROTEINS; PNEUMONIA, MYCOPLASMA; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA; RNA INTERFERENCE; UP-REGULATION;

EID: 35748980587     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3995     Document Type: Article

References (38)

1. Martin, R. J., M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell. 2001. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107: 595-601.
2. ten Brinke, A., J. T. van Dissel, P. J. Sterk, A. H. Zwinderman, K. F. Rabe, and E. H. Bel. 2001. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 107: 449-454.
3. Wu, L., S. J. Skinner, N. Lambie, J. C. Vuletic, F. Blasi, and P. N. Black. 2000. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 16: 1148-1151.
4. Blasi, F., S. Damato, R. Cosentini, P. Tarsia, R. Raccanelli, S. Centanni, and L. Allegra. 2002. Chlamydia interaction with COPD (CIAC) study group: Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 57: 672-676.
5. Kraft, M., G. H. Cassell, J. Pak, and R. J. Martin. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121: 1782-1788.
6. Leclair, E. E. 2003. Four BPI (bactericidal/permeability-increasing protein)-like genes expressed in the mouse nasal, oral, airway and digestive epithelia. Biochem. Soc. Trans. 31: 801-805.
7. Campos, M. A., A. R. Abreu, M. C. Nlend, M. A. Cobas, G. E. Conner, and P. L. Whitney. 2004. Purification and characterization of PLUNC from human tracheobronchial secretions. Am. J. Respir. Cell Mol. Biol. 30: 184-192.
8. Li, R., A. C. Manna, S. Dai, A. L. Cheung, and G. Zhang. 2003. Crystal structure of SarS from Staphylococcus aureus. J. Bacteriol. 185: 4219-4225.
9. Chen, Z., J. Zang, J. Whetstine, X. Hong, F. Davrazou, T. G. Kutateladze, M. Simpson, Q. Mao, C. Pan, S. Dai, et al. 2006. Structural insights into histone demethylation by JMJD2 family members. Cell 125: 691-702.
10. Hardy, R. D., A. M. Rios, S. Chavez-Bueno, H. S. Jafri, J. Hatfield, B. B. Rogers, G. H. McCracken, and O. Ramilo. 2003. Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob. Agents Chemother. 47: 1614-1620.
11. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64: 5326-5331.
12. Moraes, T. J., J. Plumb, R. Martin, E. Vachon, V. Cherepanov, A. Koh, C. Loeve, J. Jongstra-Bilen, J. H. Zurawska, J. V. Kus, et al. 2006. Abnormalities in the pulmonary innate immune system in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34: 364-374.
13. Chu, H. W., S. Jeyaseelan, J. G. Rino, D. R. Voelker, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin. 2005. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J. Immunol. 174: 5713-5719.
14. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon-γ (IFN-γ) is required for Fas-mediated apoptosis of T lymphocytes. J. Exp. Med. 196: 999-1005.
15. Refaeli, Y., K. A. Field, B. C. Turner, A. Trumpp, and J. M. Bishop. 2005. Overexpression of MYC can break B-cell tolerance. Proc. Natl. Acad. Sci. USA 102: 4097-4102.
16. Matta, H., B. Hozayev, R. Tomar, P. Chugh, and P. M. Chaudhary. 2003. Use of lentiviral vectors for delivery of small interfering RNA. Cancer Biol. Ther. 2: 206-210.
17. Chu, H. W., J. M. Honour, C. A. Rawlinson, R. J. Harbeck, and R. J. Martin. 2003. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect. Immun. 71: 1520-1526.
18. Chu, H. W., J. G. Rino, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin. 2005. Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am. J. Physiol. 289: L125-L133.
19. Kelly, M. M., R. Leigh, P. Bonniaud, R. Ellis, J. Wattie, M. J. Smith, G. Martin, M. Panju, M. D. Inman, and J. Gauldie. 2005. Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am. J. Respir. Cell Mol. Biol. 32: 99-107.
20. Chu, H. W., S. Balzar, J. Y. Westcott, J. B. Trudeau, G. Seedorf, and S. E. Wenzel. 2004. Transforming growth factor β2 induces bronchial epithelial mucin expression in asthma. Am. J. Pathol. 165: 1097-1106.
21. Trudeau, J., H. Hu, K. Chibana, H. W. Chu, J. Y. Westcott, and S. E. Wenzel. 2006. Selective down-regulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J. Allergy Clin. Immunol. 117: 1446-1454.
22. Chu, H. W., J. A. Campbell, J. G. Rino, R. J. Harbeck, and R. J. Martin. 2004. Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice. J. Infect. Dis. 189: 1119-1127.
23. Chu, H. W., S. Balzar, J. Y. Westcott, J. B. Trudeau, Y. Sun, D. J. Conrad, and S. E. Wenzel. 2002. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin. Exp. Allergy 32: 1558-1565.
24. Bingle, C. D., and C. J. Craven. 2002. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11: 937-943.
25. Chu, H. W., J. L. Halliday, R. J. Martin, D. Y. M. Leung, S. J. Szefler, and S. E. Wenzel. 1998. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am. J. Respir. Crit. Care Med. 158: 1936-1944.
26. Yang, J., W. C. Hooper, D. J. Phillips, and D. F. Talkington. 2002. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect. Immun. 70: 3649-3655.
27. LeClair, E. E. 2003. Four reasons to consider a novel class of innate immune molecules in the oral epithelium. J. Dent. Res. 82: 944-950.
28. Levy, O., C. E. Ooi, P. Elsbach, M. E. Doerfler, R. I. Lehrer, and J. Weiss. 1995. Antibacterial proteins of granulocytes differ in interaction with endotoxin: comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J. Immunol. 154: 5403-5410.
29. Bals, R., and P. S. Hiemstra. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23: 327-333.
30. Nomura, I., E. Goleva, M. D. Howell, Q. A. Hamid, P. Y. Ong, C. F. Hall, M. A. Darst, B. Gao, M. Boguniewicz, J. B. Travers, and D. Y. Leung. 2003. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171: 3262-3269.
31. Weston, W. M., E. E. LeClair, W. Trzyna, K. M. McHugh, P. Nugent, C. M. Lafferty, L. Ma, R. S. Tuan, and R. M. Greene. 1999. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J. Biol. Chem. 274: 13698-13703.
32. Zhu, Z., C. G. Lee, T. Zheng, G. Chupp, J. Wang, R. J. Homer, P. W. Noble, Q. Hamid, and J. A. Elias. 2001. Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am. J. Respir. Crit. Care Med. 164: S67-S70.
33. Chen, Q., L. Rabach, P. Noble, T. Zheng, C. G. Lee, R. J. Homer, and J. A. Elias. 2005. IL-11 receptor α in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 174: 2305-2313.
34. Ghafouri, B., K. Irander, J. Lindbom, C. Tagesson, and M. Lindahl. 2006. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J. Proteome Res. 5: 330-338.
35. Ghafouri, B., E. Kihlstrom, C. Tagesson, and M. Lindahl. 2004. PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim. Biophys. Acta 1699: 57-63.
36. Ghafouri, B., E. Kihlstrom, B. Stahlbom, C. Tagesson, and M. Lindahl. 2003. PLUNC (palate, lung and nasal epithelial clone) proteins in human nasal lavage fluid. Biochem. Soc. Trans. 31: 810-814.
37. Ghafouri, B., B. Stahlbom, C. Tagesson, and M. Lindahl. 2002. Newly identified proteins in human nasal lavage fluid from non-smokers and smokers using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2: 112-120.
38. Lindahl, M., B. Stahlbom, and C. Tagesson. 2001. Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight. Electrophoresis 22: 1795-1800.